Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13 (10), e0206448

Cancer Care and Public Health Policy Evaluations in France: Usefulness of the National Cancer Cohort


Cancer Care and Public Health Policy Evaluations in France: Usefulness of the National Cancer Cohort

Philippe Jean Bousquet et al. PLoS One.


Background: In the context of the national Cancer Plans of France that have changed the healthcare landscape, it has become necessary to better document and assess the related actions, and to promote research and understanding. The national cancer cohort, an exhaustive population-based cohort, was set up on the basis of the National Health Data System (SNDS) by the French National Cancer Institute.

Objectives: The aim is to describe the French national cancer cohort.

Methods: All people living in France (67 million population) with universal insurance coverage and diagnosed, treated or followed up for a cancer, such as survivors, are included and will be followed up for 25 years. It contains all healthcare consumptions and reimbursements (i.e. hospitalization, outpatient care, medication…) since 2010. Every year, around 650 000 new cases are included.

Results: From 2010 to 2015, 6.2 million subjects have been included. Most subjects were entered in 2010, in 2015 it concerned 0.6 million. In 2015, the median age was 65 [54-76]; 51% were women. The primary cancer organ could be attributed with certitude to 87% of the people. The most frequent locations were skin (16%), breast (15%), prostate (12%), colon-rectum (11%) and lung (9%). In 2015, 40% of included subjects underwent surgery for cancer, 16% chemotherapy at hospital and 11% at least one session of radiotherapy.

Conclusion: Based on SNDS, the cancer cohort has been designed to study cancer care use in the short-, medium- and long-term, and evaluate healthcare and public health policies.

Conflict of interest statement

The authors have declared that no competing interests exist.


Fig 1
Fig 1. Patient selection and data extraction.
Fig 2
Fig 2. Number of patients included in the cancer cohort between 2010 and 2015.
Fig 3
Fig 3. Information types for inclusion by subject between 2010 and 2015.

Similar articles

See all similar articles

Cited by 2 articles


    1. INCa. Plan Cancer 2003–2007. Boulogne-Billancourt, France: Institut national du cancer2003.
    1. INCa. Plan Cancer 2009–2013. Boulogne-Billancourt, France: Institut national du cancer2009 Janvier 2009.
    1. INCa. Plan Cancer 2014–2019. Boulogne-Billancourt, France: Institut national du cancer2015 Février 2015.
    1. INCa. Programme national de réduction du tabagisme 2014–2019. Boulogne-Billancourt, France: Institut national du cancer2014.
    1. Cowppli-Bony A, Uhry Z, Remontet L, al e. Survie des personnes atteintes de cancer en France métropolitaine 1989–2013—Partie 1—Tumeurs solides: Partenariat Francim/HCL/InVS/INCa2016 Février 2016.

Publication types

Grant support

The study and the Cancer cohort are self-funded by the French national cancer institute.